| Nancy F Garza, MD | |
|
250 Cherokee Professional Park, Maryville, TN 37804-5153 | |
| (865) 681-0103 | |
| (865) 681-9840 |
| Full Name | Nancy F Garza |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 18 Years |
| Location | 250 Cherokee Professional Park, Maryville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104921469 | NPI | - | NPPES |
| 3833858 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 41417 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blount Memorial Hospital | Maryville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fort Sanders Perinatal Center | 3577505536 | 27 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced it submitted a supplemental New Drug Application with the U.S. Food and Drug Administration (FDA) for a Ready-to-Use formulation of FUSILEV (levoleucovorin) for Injection.
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber Cancer Institute who led the worldwide clinical trial.
Stryker Neurovascular announced today that its Trevo Pro Retriever has been granted 510(k) market clearance by the U.S. Food and Drug Administration. The Trevo Pro Retriever is the next generation in clot removal technology from Stryker, utilizing proprietary Stentriever Technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke.
Liquid laundry and dishwasher detergent pods are an emerging source of chemical exposure in children. When squeezed or bitten into, these pods can burst and send detergent into the mouth, nose, and eyes.
› Verified 2 days ago
| Entity Name | Fort Sanders Perinatal Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003811381 PECOS PAC ID: 3577505536 Enrollment ID: O20050614001362 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced it submitted a supplemental New Drug Application with the U.S. Food and Drug Administration (FDA) for a Ready-to-Use formulation of FUSILEV (levoleucovorin) for Injection.
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber Cancer Institute who led the worldwide clinical trial.
Stryker Neurovascular announced today that its Trevo Pro Retriever has been granted 510(k) market clearance by the U.S. Food and Drug Administration. The Trevo Pro Retriever is the next generation in clot removal technology from Stryker, utilizing proprietary Stentriever Technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke.
Liquid laundry and dishwasher detergent pods are an emerging source of chemical exposure in children. When squeezed or bitten into, these pods can burst and send detergent into the mouth, nose, and eyes.
› Verified 2 days ago
| Entity Name | All Women's Care, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437251295 PECOS PAC ID: 2264530435 Enrollment ID: O20070612000348 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced it submitted a supplemental New Drug Application with the U.S. Food and Drug Administration (FDA) for a Ready-to-Use formulation of FUSILEV (levoleucovorin) for Injection.
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber Cancer Institute who led the worldwide clinical trial.
Stryker Neurovascular announced today that its Trevo Pro Retriever has been granted 510(k) market clearance by the U.S. Food and Drug Administration. The Trevo Pro Retriever is the next generation in clot removal technology from Stryker, utilizing proprietary Stentriever Technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke.
Liquid laundry and dishwasher detergent pods are an emerging source of chemical exposure in children. When squeezed or bitten into, these pods can burst and send detergent into the mouth, nose, and eyes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nancy F Garza, MD 250 Cherokee Professional Park, Maryville, TN 37804-5153 Ph: (865) 681-0103 | Nancy F Garza, MD 250 Cherokee Professional Park, Maryville, TN 37804-5153 Ph: (865) 681-0103 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced it submitted a supplemental New Drug Application with the U.S. Food and Drug Administration (FDA) for a Ready-to-Use formulation of FUSILEV (levoleucovorin) for Injection.
A new targeted drug demonstrated its ability to control metastatic gastrointestinal stromal tumor, an uncommon and life-threatening form of sarcoma, after the disease had become resistant to all existing therapies, report investigators at Dana-Farber Cancer Institute who led the worldwide clinical trial.
Stryker Neurovascular announced today that its Trevo Pro Retriever has been granted 510(k) market clearance by the U.S. Food and Drug Administration. The Trevo Pro Retriever is the next generation in clot removal technology from Stryker, utilizing proprietary Stentriever Technology for optimized clot integration and retrieval in patients experiencing acute ischemic stroke.
Liquid laundry and dishwasher detergent pods are an emerging source of chemical exposure in children. When squeezed or bitten into, these pods can burst and send detergent into the mouth, nose, and eyes.
› Verified 2 days ago
Gary Merlin Mason, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1503 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-980-5290 Fax: 865-980-5295 | |
Samuel Dixie Evans, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-981-2155 | |
Ms. Tasheema Lanell Fair, M.D Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 250 Cherokee Professional Park, Maryville, TN 37804 Phone: 865-681-0103 | |
Patrick L Morgan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 270 Bmh Physicians Office Building, Maryville, TN 37804 Phone: 865-546-1642 Fax: 865-681-7949 | |
Annalysa M Johnson, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 270 Bmh Physicians Office Building, Maryville, TN 37804 Phone: 865-546-1642 Fax: 865-681-7949 | |
Elizabeth D Lebrun, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1033 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-681-0103 Fax: 865-681-9840 |